| CLINICAL INVESTIGATOR RESEARCH PROGRAM | ||
| James Rubenstein | 2008 | The Role of Interleukin-4 in the Pathogenesis of Non-Hodgkin's Lymphoma |
| Zhen Jane Wang | 2008 | CT perfusion of early response to anti-angiogenic therapy in metastatic renal cell carcinoma |
| Benjamin Houseman | 2008 | Using microfluidic technology to study dynamic kinase inhibitor therapy |
| Ma Somsouk | 2008 | CT Colonography for Colorectal Cancer Screening: Comparing Risks and Benefits in Geriatric vs. non-Geriatric Populations |
| Robert Blelloch, MD, PhD | 2006 | Establishment of a Stem Cell Model of Prostate Cancer |
| Electron Kebebew, MD | 2006 | Molecular Classification of Adrenocortical Neoplasms |
| Jeff Simko, MD | 2006 | Magnetic Resonance Profiles of Renal Tumors |
| Karen Smith-McCune, MD, PhD | 2005 | An Exploratory Clinical Trial of Zolendronate in CIN 2/3 |
| Katherine Rauen, MD, PhD | 2004 | Genomic Analysis of Patients with Familial Cancers |
|
Neal Fischbach, MD Thomas Martin, MD |
2004 | Serum Protein Expression Profiling for the Early Diagnosis of Graft Versus Host Disease and Invasive Aspergillosis in Bone Marrow Transplant Patients |
| Mary Beattie, MD | 2004 | Estradiol and Breast Cancer Prevention: Cost Effectiveness |
| Andrew Ko, MD | 2003 | Detection of Micrometastases in Pancreatic Cancer |
| Lawrence Fong, MD | 2003 | Dendritic Cell Vaccination for Colorectal Cancer |
| Alexander Gottschalk, MD, PhD | 2001 | The PI3K Pathway as a Prognostic Factor for Prostate Cancer |
| Catherine Park, MD | 2001 | beta1 Integrin-Targeted Antibody Therapy for Breast Cancer |
| Emily Bergsland, MD | 2001 | Cytoxan and Celebrex as Antiangiogenic Therapy for Hepatoma |
| Shelley Hwang, MD | 2001 | Primary Hormonal Therapy of Ductal Carcinoma in situ of the Breast |
| James L. Rubenstein, MD, PhD | 2000 | Prognostic Factors and Drug Resistance in Non-Hodgkin's Lymphoma |
| Daniel M. Ramos, DDS, PhD | 1999 | A Model for avb 3 Mediated Metastatic Oral Melanoma |
| James L. Rubenstein, MD, PhD | 1999 | Rituximab in the Treatment of Primary CNS Lymphoma |
| Judith M.E. Walsh, MD, MPH | 1999 | Improving Colon Cancer Screening in the Community |
| Ping Xia, PhD | 1999 | Computer Optimization of Intensity Modulated Radiotherapy |
| Karla Kerlikowske, MD | 1999 | Breast Density to Predict Cancer Risk |
| Mayumi Nakagawa, MD, PhD | 1999 | Identifying Epitopes of HPV 16 E7 Protein Using Tetramers |
| Daphne Haas-Kogan, MD | 1999 | The PTEN Tumor Suppressor Gene in Human Malignant Glioma Brain Tumors |
| David M. Reese, MD | 1999 | HER2 Expression in Hormone-Refractory Prostate Cancer |
| Peter H. Sayre, MD, PhD | 1999 | HLA Structural Disparities in Unrelated Transplantation |
| Mark W. Frohlich, MD | 1998 | Detection of Prostate Cancer Micrometastases in the Peripheral Blood |
| STEWART TRUST CANCER RESEARCH AWARD | ||
| John Murnane | 2009 | Mechanisms of regulation of chromosome healing in mammalian cells |
| Dorie Apollonio | 2009 | Translating tobacco control research into public knowledge |
| Claudia Petritsch | 2009 | Defective asymmetric cell division as a cause for aberrant self-renewal, impaired differentiation and malignancy |
| Joachim Li | 2009 | Exploring re-replication as a novel source of chromosome instability |
| Xin Chen | 2009 | Role of EphA2 in HCC pathogenesis |
| David Toczyski | 2008 | Identifying the target of the human "Radio-resistant DNA synthesis" checkpoint |
| Marcella Fasso | 2008 | Immunological Characterization of SPAS-2/NGLY1 a Novel Prostate Cancer Tumor Antigen Defined by CTLA-4 Blockade |
| Michael Potter | 2008 | A Pharmacy-Based Intervention to Increase Colorectal Cancer Screening: Offering Fecal Immunochemical Tests at the time of Annual Flu Shots |
| Jeroen Roose | 2008 | The mechanism of RasGRP-induced lymphomagenesis in T-ALL/L and mouse models of the human disease |
| Elad Ziv | 2008 | Admixture and Genetics of Multiple Myeloma among African Americans |
| Emmanuelle Passegue | 2008 | Deconstructing myeloid leukemia development in junB-deficient mice |
| David Stokoe, PhD | 2007 | Determine the Role of PDK-1 in Stem Cell Pluripotency and Differentiation |
| Jayanta Debnath, MD | 2007 | Discovering novel autophagy inhibitors for cancer chemotherapy |
| Allan Balmain, PhD, FRSE | 2007 | K-ras pathway polymorphisms and pancreatic cancer risk |
| Zena Werb, PhD | 2007 | Role of GATA3 negative mammary stem cells in metastasis |
|
Hiten Madhani, MD, PhD |
2006 | Novel Oscillatory Induction of DNA Repair Genes to DNA Damage in a Yeast: Roles for Conserved Homologs of Circadian Clock |
|
Henry F. Van Brocklin, PhD |
2006 | Improving Paclitaxel Therapy: Molecular Imaging Approach |
|
Boris Bastian, MD |
2006 | Germline Variation of MC1R as a Modular of BRAF-Mediated Cancers |
| Frances Brodsky, DPhil | 2005 | Clathrin-ALK Translocation in Lymphomagenesis |
| Joachim Li, MD, PhD | 2005 | Exploring the Role of Rereplication in Gene Amplification |
| Limin Liu, PhD | 2005 | Role of GSNOR in Liver Tumorigenesis |
| Pamela Ling, MD, MPH | 2004 | Reversing Tobacco Marketing Research on Young Adults |
| Steven Rosen, PhD | 2004 | Role of a Novel Extracellular Sulfatase in Tumorigenesis |
| Matthew Krummel, PhD | 2004 | 2-Photon Imaging of Immune Tumor Surveillance |
| David Stokoe, PhD | 2004 | Characterization of Cells and Mice Expressing Inhibitable PDK-1 |
| D. Montgomery Bissell, MD | 2003 | The Role of Inflammation and Fibrosis in HCV- Related Liver Cancer |
| Emma Shtivelman, PhD | 2003 | Chk1is a Target of PKB/Akt in the Abrogation of G2 Checkpoint in Tumor Cells |
| Gerard Evan, PhD | 2003 | A New Technology for Target Validation in Cancer |
| R. Kip Guy, PhD | 2002 | Chemical Genetics of the PDZ Protein Interaction Domain |
| Yvonne Kapila, DDS, PhD | 2002 | LCM of Phage-Peptide-Targeted Cancer Tissue |
| Martin McMahon, PhD | 2002 | Regulation of Apoptosis by the Ras-activated Raf-MEK-ERK Pathway |
| William Seaman, MD | 2002 | Signal Regulatory Proteins in Brain Tumors |
| Allan Balmain, PhD | 2001 | Further Characterization of Aurora2 as a Modifier of Cancer Risk |
| Michael Fried, AB, PhD | 2001 | The ARF-p53 Signaling Pathway and Oncogene Cooperation |
| James D. Marks, MD, PhD | 2001 | Identification of Tumor Antigens by Mass Spectrometry |
| Rosemary J. Akhurst, PhD | 2000 | Mapping a New Modifier of Angiogenesis and Hematopoiesis |
| Gerard I. Evan, PhD | 2000 | Study of Myc Function in the Intestinal Epithelia |
| Clifford A. Lowell, MD, PhD | 2000 | Src-family Tyrosine Kinases in Promyelocytic Leukemia |
| David H. Stokoe, PhD | 2000 | Development of Novel Therapeutics for Gioblastoma |
| T.S. Benedict Yen, MD, PhD | 2000 | Effect of ET743 on Hepatitis B Virus Gene Expression |
| Ira Herskowitz, PhD | 1999 | Genetic Control of Cisplatin Resistance in Yeast |
| Nigel P. Killeen, PhD | 1999 | A Mouse Model of Myeloid Leukemia |
| Emma Shtivelman, PhD | 1999 | Induction of Antiangiogenic Activity by Metastasis Suppressor Gene CC3 |
| David Toczyski, PhD | 1999 | A Novel Role for Cdc5 in Checkpoint Adaptation |
| William W. Weiss, MD, PhD | 1999 | Cancer Genes |
| AMERICAN CANCER SOCIETY INSTITUTIONAL RESEARCH AWARD | ||
| Danica Galonic Fujimori, PhD | 2009 | Understanding the Molecular Basis of Lung Cancer Proliferation |
| Michelle Hermiston, MD, PhD | 2009 | Predicting Clinical Response in T-cell Acute Lymphoblastic Leukemia/Lymphoma |
| Bonnie Joe, MD, PhD | 2009 | Image-Directed Tissue Analysis of Breast Cancer |
| Claudia Petritsch, PhD | 2009 | Novel regulators of the neoplastic transformation of stem and progenitor cells |
| Andrei Goga | 2008 | Oncogene Cooperation and Targeted Therapeutics of Liver Cancer |
| Laura Koth | 2008 | Regulation of MMP-12 in Lung Cancer |
| Jiang He | 2008 | Novel mesothelioma specific antibody for diagnostic imaging and therapy |
| Katja Bruckner | 2008 | Novel suppressors of cell survival and proliferation |
| Electron Kebebew, MD | 2006 | Molecular Markers of Thyroid Neoplasms |
| Scott Oakes, MD | 2006 | Dissecting Cell Death Signaling Downstream of ER Stress |
| Xin Chen, PhD | 2004 | Functions of Hedgehog Interacting Protein in HCC Pathogenesis |
| James Rubenstein, MD, PhD | 2004 | Identification of Prognostic Biomarkers in Primary CNS Lymphoma |
| Jean Lee Nakamura, MD | 2004 | The Role of mTOR in Ras-mediated Gliomagenesis |
| Judith Prochaska, PhD, MPH | 2004 | Training in Nicotine Dependence Treatment in Psychiatry: A Survey of Residency Training Directors |
| Neal Fischbach, MD | 2003 | The HOXB6 Homeobox Gene in Normal and Malignant Hematopoiesis |
| Catherine Klifa, PhD | 2003 | Study of Breast Tissue Using Combined Optical and Magnetic Resonance Imaging |
| Osamu Tetsu, MD, PhD | 2003 | Cyclin D1 Stability in Cancer Cells |
| Gabriele Bergers, PhD | 2002 | Do Perivascular Cells Contribute to the Maturation of the Tumor Vasculature via PDGF Receptor Beta Signaling |
| Peter Chin-Hong, MD | 2002 | Self-Collected Samples to Diagnose Anal Dysplasia in Men |
| Lawrence Fong, MD | 2002 | T Cell Receptor Affinity of Vaccine-Induced Tumor-Specific T Cells |
| Bin Liu, PhD | 2002 | Evolving Human Antibody Gene Diversity Library on Ovarian Cancer Cells |
| Ping Xia, PhD | 2002 | Detection of Patient Setup Errors in Radiotherapy |
| Christopher Haqq, MD, PhD | 2001 | Prostate Gene Expression in High and Low Risk Ethnic Group |
| Mignon Lee-Cheun Loh, MD | 2001 | Cloning and Characterization of TEL/TRKC Rearrangements in Infantile Solid Tumor |
| Richard C.K. Jordan, DDS, PhD | 2001 | Characterization of Novel Biomarkers in Oral Precancer |
| Tung Nguyen, MD | 2001 | HPV and Cervical Cancer in Vietnamese American Women |
| Lisa M. Coussens, PhD | 2000 | Regulation of Intracellular Signaling Pathways by Gelatinase B/MMP-9 |
| L. Yvonne Kapila, DDS, PhD | 2000 | Fibronectin-Mediated SCC Cell Apoptosis |
| W. Michael Korn, MD | 2000 | The Adenovirus Receptor CAR in Gastrointestinal Cancer |
| Timothy P. Quinn, MD | 2000 | Development of VEGFR2Fas: A VEGF-triggered Endothelial Death Receptor |
| Kenneth D. Aldape, MD | 1999 | QuMA to Detect 1p Loss in Oligodendroglioma |
| Colin Collins, PhD | 1999 | Toward a Function for ZNF217 |
| Lisa M. Coussens, PhD | 1999 | Proteases and Genomics in a Mouse Model of Epithelial Cancer |
| Mark W. Frohlich, MD | 1999 | Development of a Murine Model for Prostate Bone Metastases |
| Kip R. Guy, PhD | 1999 | Inhibition of mdm2/p53 Binding |
| Volker Doetsch | 1998 | Structural Characterization of the Protein p63 |
| Peter H. Sayre, MD | 1998 | Structure-Based Design of Targeted Viral env Proteins |
| Karen Smith-McCune, MD, PhD | 1998 | Expression of HPV16 E7 Target Genes in the Human Cervix |
| David Stokoe, PhD | 1998 | Role of Protein Kinase B/Akt in Cell Transformation |
| Pengchin Chen | 1997 | Molecular Epidemiology of Astrocytic Glioma |
| Joachim Li, MD, PhD | 1997 | Analysis of Genome Instability in DNA Replication Mutants |
| Mary C. Nakamura, MD | 1997 | Identification of NK Receptor Ligands on Tumor Cells |
| Stephen L. Nishimura, MD | 1997 | Novel Anti-Proliferative Effect of avb8 on Carcinoma Cell Growth |
